Alzheimer’s drug donanemab slows disease progression in global trial; Report Science July 18, 2023 United Kingdom: A new study has stated that the new drug donanemab will become a turning point in the fight…
Experimental Alzheimer’s drug slows cognitive decline in late-stage trial; Eli Lilly Home News May 4, 2023 United States: Pharmaceutical company Eli Lilly has announced the successful results of a late-stage clinical trial of its experimental drug…
